PT104619A - Complexos de proteína e métodos de rastreio - Google Patents

Complexos de proteína e métodos de rastreio Download PDF

Info

Publication number
PT104619A
PT104619A PT104619A PT10461909A PT104619A PT 104619 A PT104619 A PT 104619A PT 104619 A PT104619 A PT 104619A PT 10461909 A PT10461909 A PT 10461909A PT 104619 A PT104619 A PT 104619A
Authority
PT
Portugal
Prior art keywords
homologous
fragment
variant
human
activity
Prior art date
Application number
PT104619A
Other languages
English (en)
Inventor
Andre Xavier De Carval Valente
Yuan Gao
Greg Buck
Seth Roberts
Original Assignee
Biocant Ct De Inovacao Em Biot
Univ Virginia Commonwealth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocant Ct De Inovacao Em Biot, Univ Virginia Commonwealth filed Critical Biocant Ct De Inovacao Em Biot
Priority to PCT/EP2009/004181 priority Critical patent/WO2010000374A1/en
Priority to CA2727646A priority patent/CA2727646A1/en
Priority to US12/997,375 priority patent/US20110183425A1/en
Priority to AU2009266100A priority patent/AU2009266100A1/en
Publication of PT104619A publication Critical patent/PT104619A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

O PEDIDO DE PATENTE REFERE-SE A UM COMPLEXO DE PROTEÍNA ISOLADO COMPREENDENDO COMPONENTES POLIPEPTÍDICOS:(I) UTP2O_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; (II) PWP2 HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; (III) WDR46_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; (IV) UTP18_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; (V) MPP10_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; (VI) WDR3_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; (VII) TBL3_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; (VIII) WDR36_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO; E (IX) NOC4L_HUMAN OU UM SEU FRAGMENTO, VARIANTE OU HOMÓLOGO. O PEDIDO DE PATENTE REFERE-SE ADICIONALMENTE A UM MÉTODO DE IDENTIFICAÇÃO DE UM AGENTE QUE MODULA A QUANTIDADE, FUNÇÃO, ACTIVIDADE, COMPOSIÇÃO E/OU FORMAÇÃO DO REFERIDO COMPLEXO DE PROTEÍNA; UM MÉTODO PARA PREVENÇÃO OU TRATAMENTO DE UMA PERTURBAÇÃO OCULAR COMPREENDENDO ADMINISTRAR A UM INDIVÍDUO QUE O NECESSITE UMA QUANTIDADE ADEQUADA DE UM AGENTE QUE MODULA A QUANTIDADE, FUNÇÃO, ACTIVIDADE, COMPOSIÇÃO E/OU FORMAÇÃO DO REFERIDO UM COMPLEXO DE PROTEÍNA; E UM MÉTODO PARA AVALIAR SE UM INDIVÍDUO TEM OU DESENVOLVERÁ PROVAVELMENTE UMA PERTURBAÇÃO OCULAR COMPREENDENDO DETERMINAR SE O INDIVÍDUO TEM UMA QUANTIDADE, FUNÇÃO, ACTIVIDADE, COMPOSIÇÃO E/OU FORMAÇÃO DE UM COMPLEXO DE PROTEÍNA ALTERADA.
PT104619A 2008-06-13 2009-06-09 Complexos de proteína e métodos de rastreio PT104619A (pt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/EP2009/004181 WO2010000374A1 (en) 2008-06-13 2009-06-10 Protein complexes and screening methods
CA2727646A CA2727646A1 (en) 2008-06-13 2009-06-10 Protein complexes and screening methods
US12/997,375 US20110183425A1 (en) 2008-06-13 2009-06-10 Protein Complexes and Screening Methods
AU2009266100A AU2009266100A1 (en) 2008-06-13 2009-06-10 Protein complexes and screening methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13193308P 2008-06-13 2008-06-13

Publications (1)

Publication Number Publication Date
PT104619A true PT104619A (pt) 2009-12-14

Family

ID=42026536

Family Applications (1)

Application Number Title Priority Date Filing Date
PT104619A PT104619A (pt) 2008-06-13 2009-06-09 Complexos de proteína e métodos de rastreio

Country Status (6)

Country Link
US (1) US20110183425A1 (pt)
EP (1) EP2307449A1 (pt)
AU (1) AU2009266100A1 (pt)
CA (1) CA2727646A1 (pt)
PT (1) PT104619A (pt)
WO (1) WO2010000374A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
AU2002367554A1 (en) * 2001-12-20 2003-09-09 Cellzome Ag Protein complexes and methods for their use
US20070172919A1 (en) * 2006-01-26 2007-07-26 The University Of Connecticut WDR36 Gene Alterations and Glaucoma

Also Published As

Publication number Publication date
CA2727646A1 (en) 2010-01-07
WO2010000374A1 (en) 2010-01-07
EP2307449A1 (en) 2011-04-13
US20110183425A1 (en) 2011-07-28
WO2010000374A8 (en) 2011-01-20
AU2009266100A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
CO6300826A2 (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf
BR112015012789A2 (pt) composição que compreende um agente de controle biológico e um inseticida
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA015654B9 (ru) Антитела против бета-амилоидного пептида
MX2008006076A (es) Metodos, composiciones y kits para el tratamiento de condiciones medicas.
EA200801163A1 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
EA200801164A3 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
EA200901308A1 (ru) Ингибиторы белка, активирующего 5-липоксигеназу (flap)
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
WO2010034015A3 (en) Modulating the alternative complement pathway
WO2007089375A3 (en) Compositions and methods for regulating complement system
EA201170349A1 (ru) Модуляторы mif
BR112015012702A2 (pt) composição que compreende um agente de controle biológico e um fungicida
UA101309C2 (ru) Антагонисты активина-actrii и их применение для повышения уровня эритроцитов
WO2007103373A3 (en) Compositions and methods for the treatment of immunoinflammatory disorders
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BR112015012925A2 (pt) composição que compreende um agente de controle biológico e um fungicida
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
BR112014007675A2 (pt) tratamento de doença articular degenerativa
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
ATE542535T1 (de) Verwendung von azapaullonen zur vorbeugung und behandlung pankreatischer autoimmunkrankheiten

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20091014

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20131209